Summary of the necessity of implementation and practical goals of the project: Lactoferrin glycoside is an 80-kDa protein capable of binding to iron. By absorbing iron from the environment, this protein can prevent viral pathogens that need environmental iron for their function. Because the new coronavirus posed a high risk of death and did not receive definitive treatment due to the viral mutation, this study aimed to monitor the effect of lactoferrin on boosting the immune system in patients with COVID-19. Summary of project implementation method: According to statistics obtained from children with COVID-19 disease and adults in Iran, Arab countries, and India, this research was conducted in a completely randomized plan. After ensuring that the data is normal, using one Sample Kolmogorov-Smirnov Test, analyzing the data from the lactoferrin effect on increasing the strength of the immune system using 19 SPSS software, one-way analysis of variance (one way ANOVA), and a comparison with Duncan's multidimensional test between different treatments were performed. P <0.05 was considered significant.
Copyright © 2025 Archives of Pharmacy Practice. Authors retain copyright of their article if they are accepted for publication.
Developed by Archives of Pharmacy Practice